MedWatch

Pharmacosmos goes straight for rival in new phase III studies

The Danish pharmaceutical company Pharmacosmos has initiated a number of new phase III trials comparing the product Monofer to its main rival.

Photo: Pharmacosmos

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Zealand Pharma indgår australsk samarbejde

Zealand Pharma har indgået et nyt samarbejde med et australsk selskab rettet mod udvikling af peptid-baserede lægemidler mod mavetarmlidelser – det danske biotekselskabs helt store fokusområde.

Related articles